SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Celsion Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - November 2, 2020) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Celsion Corporation (NASDAQ: CLSN) ("Celsion" or the "Company") securities between November 2, 2015 and July 10, 2020 (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose: (1) defendants had significantly overstated the efficacy of...
2020-11-02 12:31 PM EST
SHAREHOLDER ALERT: Investigation of Intercept Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 2, 2020) - Holzer & Holzer, LLC is investigating whether Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) ("Intercept" or the "Company") complied with federal securities laws. In its most recent 10-Q filed with the SEC, the Company disclosed "the FDA has notified us that in the course of its routine safety surveillance, in May 2020 the FDA began to evaluate a newly identified safety signal regarding liver disorder for Ocaliva which the FDA classified...
2020-11-02 8:00 AM EST
SHAREHOLDER ALERT: Investigation of Innate Pharma Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - October 22, 2020) - Holzer & Holzer, LLC is investigating whether Innate Pharma S.A. ("Innate" or the "Company") (NASDAQ: IPHA) complied with federal securities laws. On September 8, 2020, the Company announced it had agreed to amend a previously negotiated agreement with AstraZeneca. The price of Innate's stock fell following the announcement. If you purchased shares of Innate and suffered a loss on that investment, you are encouraged to contact Corey D....
2020-10-22 1:41 PM EDT
SHAREHOLDER ALERT: Investigation of Myovant Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - September 29, 2020) - Holzer & Holzer, LLC is investigating whether Myovant Sciences Ltd. (NYSE: MYOV) ("Myovant" or the "Company") complied with federal securities laws. On September 29, 2020, the Company announced results of an additional secondary endpoint from the Phase 3 HERO study evaluating relugolix in men with advanced prostate cancer. The price of Myovant's stock fell following the announcement. If you purchased shares of Myovant and suffered a...
2020-09-29 10:30 AM EDT
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Golar Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - September 25, 2020) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Golar LNG Limited (NASDAQ: GLNG) ("Golar" or the "Company") securities between April 24, 2020 and September 24, 2020 (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose: (1) that certain employees, including Hygo's CEO, had bribed...
2020-09-25 9:49 AM EDT
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Wrap Investors and Encourages Investors With Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - September 24, 2020) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Wrap Technologies, Inc. ("Wrap" or the "Company") (NASDAQ: WRTC) securities between July 31, 2020 and September 23, 2020 (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had concealed the results of the...
2020-09-24 11:22 AM EDT